HD Steth from HD Medical screens over 50,000 children for congenital heart defects


SANTA CLARA, Calif .– (COMMERCIAL THREAD) – In recognition of World Congenital Heart Defects Awareness Week (CHD), HD Medical Inc. announces today that it has screened more than 50,000 children for CHD using HD Steth â„¢. These screenings have been carried out in several locations in India, helping to save more than 35 lives to date. HD Medical plans to expand screening to more than 500,000 children worldwide. Children diagnosed with coronary heart disease received life-saving treatments and surgeries from Sri Sathya Sai Sanjeevani Hospitals in India.

Coronary heart disease is the most common type of birth defect. One in 100 babies are born with coronary heart disease worldwide, and nearly 40,000 infants in the United States are born with coronary heart disease each year. In India, about 300,000 children are born with coronary heart disease each year and about 25 percent die before their first birthday. Lack of early detection and sophisticated pediatric care is the cause of more than 250 child deaths every day in India. Conventional stethoscopes used for screening gave 28 percent false positives and 51 percent false negatives when used by laypersons and health workers. Although the ultrasound echocardiogram is a more accurate alternative, the high cost of the equipment and the low availability of trained healthcare professionals have limited their use.

HD Medical’s FDA-approved HD Steth solves this problem by providing a cost-effective, easy-to-use solution for non-specialists and primary healthcare workers. HD Steth has been tested and validated in a clinical study involving 1,200 children, with a sensitivity of 91% and a specificity of 99% for the detection of heart murmurs caused by coronary heart disease compared to ultrasound echocardiograms as a reference to Sri Sathya Sai Sanjeevani Hospital in Raipur, Chhattisgarh State in central India. Based on this study, HD Steth has been adopted into an extensive coronary heart disease screening program in their group hospitals and medical screening programs in several locations in India as follows:

  • Sai Sanjeevani Hospital in Palwal, Haryana: 12,974

  • Sai Sanjeevani Hospital in Kharghar, Maharashtra: 8,020

  • Sai Sanjeevani Hospital in Raipur, Chhattisgarh: 2,000

  • Sai Sanjeevani – Niraamaya Bastar Initiative: 1,000

  • Sai Sarla Memorial Hospital, Chickaballapur, Karnataka: 19,650

  • Sai Arogya Vahini Trust Mobile Medical Clinics, Calcutta, West Bengal: 8,450

  • Total number of children screened: 52,094
  • Total number of children screened and confirmed with CHD: 90+
  • Total number of children saved through heart surgeries: 36+

Sri Sathya Sai Sanjeevani Hospitals in Maharashtra, Chhattisgarh and Haryana are India’s largest providers of completely free pediatric cardiac procedures, performing nearly 14,000 surgeries and catheter procedures since 2012. “The centers are committed to invest in child health initiatives for a healthier nation in the future by providing completely free quality health care, ”said Mr. C Sreenivas, President of Sai Sanjeevani Hospitals. “HD Medical’s HD Steth device is very useful in screening children with coronary artery disease at an early stage so that rapid surgery may be possible to save their lives. We recently signed a memorandum of understanding between the state government of Chhattisgarh and HD Medical to screen 77,000 children in Bastar, a remote tribal region. HD Steth enables healthcare workers to screen children for coronary heart disease and refer them for follow-up care in our hospitals.

“HD Steth is very easy to use by non-specialists with minimal training requirements for cardiac auscultation and as a screening tool. We launched a screening program for more than 100,000 children in Chickaballapur district in Karnataka state in October 2020 and so far we have tested nearly 20,000 children despite COVID-19, ”said the Dr Satish Babu, a distinguished endocrinologist trained at Cambridge University Hospital, King’s College. Hospital and Cardiff University Hospital in UK and currently practicing at Sri Sathya Sai Sarla Memorial Hospital, Muddenahalli near Bengaluru, Karnataka.

“We have also extended the HD Steth screening program to countries such as Fiji, Sri Lanka, Nigeria, Malaysia and the United States,” said Arvind Thiagarajan, Founder and CEO of HD Medical. “These screenings will target 500,000 children within a year, demonstrating HD Medical’s commitment to the cause of saving children through early detection of coronary heart disease with better technology.

For partnerships: [email protected]

About HD Medical, Inc.

HD Medical, Inc. is a Silicon Valley innovator of digital health solutions for AI-based cardiovascular disease (CVD) detection and management. HD Steth â„¢ has received FDA clearance (K201299). The company provides smart cardiac care products and solutions globally to healthcare professionals and institutions through channel partners and through website. Visit www.hdmedicalgroup.com.

Note to editors: HD Steth is a registered trademark of HD Medical, Inc. All other organization names are the property of their respective owners.